The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler

Respiratory Medicine

Volumn 100, Issue 1, 2006, Pages 20-25

  Masoli, Matthew ^a   Williams, Mathew ^a   Weatherall, Mark ^b   Beasley, Richard ^a,c  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Asthma; Bronchodilation; Budesonide; Circadian rhythm; Formoterol

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; PLACEBO;

ADULT; AIRWAY CONDUCTANCE; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHODILATING ACTIVITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHRONOTHERAPY; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 29844440451     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.04.012     Document Type: Article

References (29)

1. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute, 1997. NIH Publication No. 97-4051.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute, 2002. NIH Publication No. 02-3659.
3. B. Bender Overcoming barriers to nonadherence in asthma treatment J Allergy Clin Immunol 109 2002 S554-S559
4. C.R. Horn T.J.H. Clark G.M. Cochrane Compliance with inhaled therapy and morbidity from asthma Respir Med 84 1990 67-70
5. C.M. Bosley D.T. Parry G.M. Cochrane Patient compliance with inhaled medication: Does combining beta-agonists with corticosteroids improve compliance? Eur Respir J 7 1994 504-509
6. M. Yeung S.A. O'Connor D.T. Parry et al. Compliance with prescribed drug therapy in asthma Respir Med 88 1994 31-35
7. C.S. Rand R.A. Wise M. Nides et al. Metered-dose inhaler adherence in a clinical trial Am Rev Respir Dis 146 1992 1559-1564
8. J.A. Cramer R.H. Mattson M.L. Prevey R.D. Scheyer V.L. Ouellette How often is medication taken as prescribed? A novel assessment technique J Am Med Assoc 261 1989 3273-3277
9. A. Claxton J. Cramer C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296-1310
10. J. Coutts N. Gibson J. Paton Measuring compliance with inhaled medication in asthma Arch Dis Child 67 1992 332-333
11. M. Masoli M. Weatherall R. Beasley Budesonide once versus twice daily administration: Meta-analysis Respirol 9 4 2004 528-534
12. National Asthma Education and Prevention programme. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Insitute, National Institutes of Health; 1997. Available from http://www.nhlbi.nih.gov.
13. S. Stephen Crossover trials in clinical research 2nd ed 2002 Wiley Chichester p. 157-85
14. J. Brown R. Prescott Applied mixed models in medicine 1999 Wiley Chichester p. 261-93
15. S. Panzer A. Dodge E. Kelly N. Jarjour Circadian variation of sputum inflammatory cells in mild asthma J Allergy Clin Immunol 111 2003 308-312
16. M. Kraft J. Pak R.J. Martin Serum cortisol in asthma: Marker of nocturnal worsening of symptoms and lung function Chronobiol Int 15 1998 85-92
17. M. Kraft R. Djukanovic S. Wilson S. Holgate R. Martin Alveolar tissue inflammation in asthma Am J Respir Crit Care Med 154 1996 1505-1510
18. J.F. Morrison S.B. Pearson The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma Br J Clin Pharmacol 28 5 1989 545-549
19. J.A. Van Noord J.J. Smeets J.A.M. Raaijmakers A.M. Bommer F.P.V. Maesen Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action Eur Respir J 9 1996 1684-1688
20. A. Ullman N. Svedmyr Salmeterol, a new long acting inhaled beta-2-adrenoceptor agonist: A comparison with salbutamol Thorax 43 1988 674-678
21. M. Masoli M. Weatherall J. Ayling M. Williams R. Beasley The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler Respir Med 99 2005 545-552
22. N.B. Pride Assessment of changes in airway calibre. I. Tests of forced expiration Br J Clin Pharmacol 8 1979 193-203
23. A.E. Tattersfield I.M. Keeping Assessing change in airway calibre-measurement of airway resistance Br J Clin Pharmacol 8 1979 307-319
24. E.Y. Derom R.A. Pauwels Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic Thorax 47 1992 30-33
25. A.J.M. Schreurs H.E.J. Sinninghe Damste C.S. de Graaff A.P.M. Greefhorst A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients Eur Respir J 9 1996 1678-1683
26. K. Rabe R. Jorres D. Nowak N. Behr H. Magnussen Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 h in bronchial asthma Am Rev Respir Dis 147 1993 1436-1441
27. R.J. Martin L.C. Cicutto H.R. Smith R.D. Ballard R.S. Szefler Airways inflammation in nocturnal asthma Am Rev Respir Dis 143 1991 351-357
28. R.J. Martin Therapeutic significance of distal airway inflammation in asthma J Allergy Clin Immunol 109 2002 S447-S460
29. R. Buhl J.P. Creemers V. Vondra N.A. Martelli I.P. Naya T. Ekstrom Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma Respir Med 97 2003 323-330